1. Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia. (3rd October 2019) Authors: Daher-Reyes, Georgina S.; Merchan, Brayan M.; Yee, Karen W. L. Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 10(2019) Page Start: 835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗